Charles River Laboratories CRL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$14.8M-157% | -$276.29M— | $55.56M-21.0% | $52.69M-44.1% | $25.88M-65.3% | ||
| $67.15M-44.2% | $78.28M-23.3% | $85.16M-3.4% | $119.51M+38.8% | $120.36M+41.0% | ||
| $22.38M+70.4% | $17.63M+2.3% | $23.27M+20.4% | $17.05M+2.8% | $13.14M-21.5% | ||
| -$29.42M-54.5% | -$60.17M-45.2% | —— | -$21.99M-81.9% | -$19.04M-1,829% | ||
| $15.86M+50.0% | $128.82M-34.8% | $4.98M+61.3% | $20.63M+134% | $10.58M+94.7% | ||
| -$117.98M-3,595% | —— | —— | —— | $3.38M+612% | ||
| $47K-97.7% | $1.5M-77.1% | $2.37M-32.4% | $184K-95.3% | $2.01M+139% | ||
| $65.32M+123% | -$27.63M-734% | -$26.6M-54.4% | -$10.86M+40.8% | $29.35M+69.9% | ||
| -$26M-219% | $3.5M+216% | $31.33M+876% | —— | $21.88M+491% | ||
| $20.46M-19.0% | —— | $24.51M+3,819% | —— | $25.25M+396% | ||
| -$83.76M-649% | $0+100% | $42.88M— | $23.73M+294% | $15.26M+173% | ||
| $8.52M+310% | —— | $43.07M— | $26.26M+92.6% | -$4.05M-112% | ||
| $5.2M+528% | -$25.82M-621% | -$23.63M-535% | $12.52M— | -$1.21M-106% | ||
| $41.08M-76.1% | $147.52M-7.4% | $213.83M-15.1% | $204.6M+5.7% | $171.7M+32.2% | ||
| $55.91M-5.8% | $88.95M+17.6% | $35.58M-8.1% | $35.3M-10.6% | $59.32M-25.0% | ||
| $405.01M— | $0— | $0— | $0-100% | $0— | ||
| $8.49M+60.2% | $7.53M-1.1% | $4.45M-54.2% | $2.79M-87.1% | $5.3M-61.8% | ||
| $60.1M+245% | —— | —— | —— | $17.44M— | ||
| -$407.85M-797% | -$92.81M-21.9% | -$33.7M-58.0% | -$37.34M+39.6% | -$45.48M+47.0% | ||
| $208.29M-41.0% | $96K-22.6% | $93K-99.9% | $7.35M-17.5% | $353.13M+3,676% | ||
| $912.46M+119% | $156.67M+49.5% | $107.5M-54.4% | $547.02M+24.2% | $416.34M+38.4% | ||
| $355.68M+138% | $207.82M+17.6% | $253.79M-23.0% | $738.31M+6.3% | $149.39M-48.9% | ||
| $1.22M— | $711K-7.4% | $2K-99.7% | $1K-99.9% | $0-100% | ||
| $347.72M+430% | -$51.86M+31.6% | -$152.62M+26.5% | -$226.92M+20.6% | -$105.33M-674% | ||
| $1.25M-76.3% | $3.93M+129% | —— | $12.67M+479% | $5.27M+163% | ||
| -$17.8M-168% | $6.78M+212% | $24.48M— | -$46.99M+70.2% | $26.16M-51.6% | ||
| -$117.98M-3,595% | —— | —— | —— | $3.38M+612% | ||
| $15.86M+50.0% | $222.9M+546% | $4.98M+61.3% | $20.63M+134% | $10.58M+94.7% | ||
| -$135K-101% | $15.19M— | -$1.1M-116% | —— | $9.17M+49.3% | ||
| -$83.76M-649% | $0+100% | $42.88M— | $23.73M+294% | $15.26M+173% | ||
| $1.49M-78.0% | $1.75M-93.5% | $0-100% | $4.31M+168% | $6.76M+278% | ||
| $34.68M+1,029% | —— | -$1.04M+67.6% | —— | -$3.73M-929% | ||
| $47K-97.7% | $1.5M-77.1% | $2.37M-32.4% | $184K-95.3% | $2.01M+139% | ||
| -$1.14M+89.0% | —— | —— | —— | -$10.37M— | ||
| $1.46M+1,501% | -$210K+95.7% | -$2.81M-23,292% | -$243K-379% | -$104K-137% | ||
| -$2M— | -$1.34M+70.6% | -$6.23M+53.7% | -$6.46M+42.5% | $0+100% | ||
| $355.68M+138% | $207.82M+17.6% | $253.79M-23.0% | $738.31M+6.3% | $149.39M-48.9% | ||
| -$14.83M-113% | $58.57M-30.1% | $178.25M-16.3% | $169.31M+9.9% | $112.37M+121% | ||
| -$14.83M-113% | $58.57M-30.1% | $178.25M-16.3% | $169.31M+9.9% | $112.37M+121% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Charles River Laboratories generate?
- Charles River Laboratories (CRL) generated $607.0M in operating cash flow over the trailing twelve months.
- What is Charles River Laboratories's free cash flow?
- After $215.7M of capital expenditures, Charles River Laboratories's free cash flow was $391.3M over the trailing twelve months, down 30.5% year over year.
- Where does Charles River Laboratories's cash flow data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
